Steven de Jong

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Combination Therapy

Signaling Pathway

Top Venues

Communications medicine

Molecular cancer therapeutics

The Journal of pathology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Daan G Knapen, Sara Hone Lopez, Derk Jan A de Groot, Jacco-Juri de Haan, Elisabeth G E de Vries, Rodrigo Dienstmann, Steven de Jong, Arkajyoti Bhattacharya, Rudolf S N Fehrmann
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer. Communications medicine 4 (1) (2024)
Daan G Knapen, Sara Hone Lopez, Derk Jan A de Groot, Jacco-Juri de Haan, Elisabeth G E de Vries, Rodrigo Dienstmann, Steven de Jong, Arkajyoti Bhattacharya, Rudolf S N Fehrmann
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer. Communications medicine 4 (1) (2024)
Daan G Knapen, Sara Hone Lopez, Derk Jan A de Groot, Jacco-Juri de Haan, Elisabeth G E de Vries, Rodrigo Dienstmann, Steven de Jong, Arkajyoti Bhattacharya, Rudolf S N Fehrmann
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer. Communications medicine 4 (1) (2024)
Jiske F Tiersma, Bernard Evers, Barbara M Bakker, Mathilde Jalving, Steven de Jong
Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities. International journal of molecular sciences 23 (7) (2022)
Marta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, Nelson K Y Wong, Shang Li, G Bea A Wisman, Aleksandra Hamilton, Joshua Hoenisch, Amy Dawson, Cheng-Han Lee, Madison Bittner, Hannah Kim, Gabriel E DiMattia, Christianne A R Lok, Cor Lieftink, Roderick L Beijersbergen, Steven de Jong, Mark S Carey, René Bernards, Katrien Berns
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition. Molecular cancer therapeutics 21 (12) (2022)
Ximena Rosas Plaza, Ton van Agthoven, Coby Meijer, Marcel A T M van Vugt, Steven de Jong, Jourik A Gietema, Leendert H J Looijenga
miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy. Cells 8 (10) (2019)
Ximena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma, Albert J H Suurmeijer, Jourik A Gietema, Marcel A T M van Vugt, Steven de Jong
Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment. Molecular cancer therapeutics 19 (2) (2019)
Thijs S Stutvoet, Arjan Kol, Elisabeth Ge de Vries, Marco de Bruyn, Rudolf Sn Fehrmann, Anton Gt Terwisscha van Scheltinga, Steven de Jong
MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells. The Journal of pathology 249 (1) (2019)
Joseph J Caumanns, Katrien Berns, G Bea A Wisman, Rudolf S N Fehrmann, Tushar Tomar, Harry Klip, Gert J Meersma, E Marielle Hijmans, Annemiek M C Gennissen, Evelien W Duiker, Desiree Weening, Hiroaki Itamochi, Roelof J C Kluin, Anna K L Reyners, Michael J Birrer, Helga B Salvesen, Ignace Vergote, Els van Nieuwenhuysen, James Brenton, E Ioana Braicu, Jolanta Kupryjanczyk, Beata Spiewankiewicz, Lorenza Mittempergher, René Bernards, Ate G J van der Zee, Steven de Jong
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (16) (2018)